By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can help patients with a type of liver disease to reverse scarring of the ...

Mets manager Carlos Mendoza gives insight into the team's 2025 infield strategy, with key changes and rising stars like Luis ...